Skip to main content
. 2017 Aug 22;7:43. doi: 10.1186/s13578-017-0170-6

Table 1.

Reagents used in this study

# Inhibitor Target Working concentration
1 DMSO Control
2 Wortmannin PI3K 1 µM
3 Flavopiridol CDK 40 nM
4 Erlotinib EGFR 1 µM
5 Ruxolitinib JAK 1 µM
6 MK-2206 AKT 1 µM
7 AICAR AMPK 2 mM
8 Y-27632 ROCK 10 µM
9 SCH772984 ERK 1 µM
10 NSC23766 Rho 10 µM
11 Enzastaurin PKC 1 µM
12 SP600125 JNK 10 µM
13 GSK2334470 PDK 1 µM
14 IPA-3 PAK 20 µM
15 Axitinib VEGFR 1 µM
16 PHA-665752 c-Met 10 µM